-
Table of Contents
HPMC K100M: A High-Viscosity Polymer for Controlled Drug Release
Hydroxypropyl methylcellulose (HPMC) is a widely used polymer in the pharmaceutical industry for its ability to control drug release. Among the various grades of HPMC, HPMC K100M stands out as a high-viscosity polymer that offers unique advantages for formulating controlled-release drug delivery systems.
What is HPMC K100M?
HPMC K100M is a cellulose ether polymer derived from natural cellulose. It is commonly used as a pharmaceutical excipient due to its biocompatibility, non-toxicity, and inertness. The “K” in HPMC K100M denotes its high viscosity, which is crucial for controlling the release of active pharmaceutical ingredients (APIs) in drug formulations.
Advantages of HPMC K100M
- High viscosity for sustained drug release
- Improved bioavailability of poorly soluble drugs
- Enhanced stability of drug formulations
- Compatibility with a wide range of APIs
Applications of HPMC K100M
HPMC K100M is commonly used in the formulation of oral solid dosage forms such as tablets and capsules. It is particularly suitable for drugs that require controlled release over an extended period. By modulating the viscosity of HPMC K100M, formulators can tailor the drug release profile to meet specific therapeutic needs.
Case Study: HPMC K100M in Matrix Tablets
A study published in the Journal of Controlled Release demonstrated the effectiveness of HPMC K100M in formulating sustained-release matrix tablets. The researchers found that by varying the concentration of HPMC K100M in the matrix, they could achieve different release profiles for the model drug. This flexibility makes HPMC K100M a versatile polymer for designing customized drug delivery systems.
Statistics on HPMC K100M Usage
According to a market research report, the global demand for HPMC K100M is expected to grow steadily in the coming years, driven by the increasing prevalence of chronic diseases and the need for long-acting drug formulations. Pharmaceutical companies are increasingly turning to HPMC K100M to develop innovative controlled-release products that improve patient compliance and therapeutic outcomes.
Conclusion
HPMC K100M is a high-viscosity polymer that offers significant advantages for formulating controlled-release drug delivery systems. Its versatility, biocompatibility, and ability to modulate drug release make it a valuable excipient in the pharmaceutical industry. As the demand for long-acting drug formulations continues to rise, HPMC K100M is poised to play a crucial role in shaping the future of drug delivery.